PPD (TMO)

Executive Summary

PPD, the clinical research business of Thermo Fisher Scientific, is a leading global contract research organization (CRO) that provides comprehensive drug development services. With a history dating back to 1985 and headquartered in Wilmington, North Carolina, PPD supports biopharmaceutical companies in bringing life-changing therapies to market. As part of Thermo Fisher, PPD benefits from significant resources and a broad portfolio of laboratory and analytical services. The company's expertise spans all phases of clinical development, including trial design, patient recruitment, data management, and regulatory submission. In an industry where outsourcing clinical trials is increasingly common, PPD's integrated approach and global footprint position it as a key partner for both large pharma and emerging biotech firms. The CRO market is projected to grow steadily, driven by R&D pipeline complexity and cost pressures, providing a favorable backdrop for PPD's continued success.

Upcoming Catalysts (preview)

• TBDNew large-scale contract wins from top biopharma clients70% success
• TBDExpansion of decentralized clinical trial capabilities60% success
• TBDContinued integration benefits from Thermo Fisher parent90% success